Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Cavco Industries
CVCO
$4.37B
| $5.85M | ﹤0.01% |
11,259
+6,264
| +125% | +$3.15M |
|
3352
Pinnacle Financial Partners Inc
PNFP
$15.3B
| $5.85M | ﹤0.01% |
55,141
+31,045
| +129% | +$3.56M |
|
3353
International Bancshares
IBOC
$4.41B
| $5.84M | ﹤0.01% |
92,674
+1,251
| +1% | +$80.9K |
|
3354
PUT
Pilgrim's Pride
PPC
$7.55B
| $5.84M | ﹤0.01% |
107,200
+6,500
| +6% | +$325K |
|
3355
Victory Capital Holdings
VCTR
$7.28B
| $5.84M | ﹤0.01% |
100,927
+36,360
| +56% | +$2.3M |
|
3356
Iron Mountain
IRM
$35B
| $5.83M | ﹤0.01% |
67,814
-101,292
| -60% | -$9.76M |
|
3357
Levi Strauss
LEVI
$8.19B
| $5.83M | ﹤0.01% |
374,006
+235,673
| +170% | +$4.1M |
|
3358
PUT
Corteva
CTVA
$56B
| $5.83M | ﹤0.01% |
92,600
-36,600
| -28% | -$2.26M |
|
3359
Atlantic Union Bankshares
AUB
$5.81B
| $5.83M | ﹤0.01% |
187,117
+127,123
| +212% | +$4.52M |
|
3360
Eton Pharmaceutcials
ETON
$1.71B
| $5.83M | ﹤0.01% |
448,804
+256,478
| +133% | +$3.88M |
|
3361
PUT
BorgWarner
BWA
$13.1B
| $5.82M | ﹤0.01% |
203,300
+131,200
| +182% | +$3.98M |
|
3362
Reinsurance Group of America
RGA
$16B
| $5.82M | ﹤0.01% |
29,581
+1,370
| +5% | +$284K |
|
3363
IonQ
IONQ
$15.9B
| $5.82M | ﹤0.01% |
263,901
-550,152
| -68% | -$17.8M |
|
3364
FNB Corp
FNB
$6.55B
| $5.82M | ﹤0.01% |
432,817
+183,940
| +74% | +$2.7M |
|
3365
TPG
TPG
$9B
| $5.82M | ﹤0.01% |
122,612
+79,220
| +183% | +$4.62M |
|
3366
CALL
Coeur Mining
CDE
$21.7B
| $5.81M | ﹤0.01% |
981,700
-25,600
| -3% | -$158K |
|
3367
PUT
Huazhu Hotels Group
HTHT
$14.7B
| $5.8M | ﹤0.01% |
156,800
+8,300
| +6% | +$287K |
|
3368
Kinsale Capital Group
KNSL
$8.67B
| $5.8M | ﹤0.01% |
11,920
+8,414
| +240% | +$3.78M |
|
|
DQ
3369
PUT
Daqo New Energy
DQ
$926M
| $5.8M | ﹤0.01% |
320,100
-321,400
| -50% | -$6.29M |
|
3370
CALL
Western Union
WU
$2.26B
| $5.8M | ﹤0.01% |
547,900
+417,300
| +320% | +$4.42M |
|
3371
iShares ESG Optimized MSCI USA ETF
SUSA
$4.14B
| $5.79M | ﹤0.01% |
50,448
+26,350
| +109% | +$3.19M |
|
|
HSAI
3372
PUT
Hesai Group
HSAI
$2.74B
| $5.79M | ﹤0.01% |
391,100
+277,500
| +244% | +$4.73M |
|
3373
PUT
AdaptHealth
AHCO
$772M
| $5.78M | ﹤0.01% |
533,300
+32,000
| +6% | +$322K |
|
3374
Charles River Laboratories
CRL
$13.9B
| $5.78M | ﹤0.01% |
38,379
-16,325
| -30% | -$2.74M |
|
|
K
3375
DELISTED
Kellanova
K
| $5.77M | ﹤0.01% |
69,968
-51,808
| -43% | -$4.25M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.